94771 ā
Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms Nitro radicals
AN IMPROVED PROCESS FOR THE PREPARATION OF NITAZOXANIDE AND INTERMEDIATES THEREOF
#2NITROTHIAZOLE DERIVATIVE AND APPLICATION THEREOF
#3CRYSTALLINE SALTS OF TIZOXANIDE AND 2-HYDROXY-N-(5-CHLORO-1,3-THIAZOL-2-YL)BENZAMIDE (RM-4848) WITH ETHANOLAMINE, MORPHOLINE, PROPANOLAMINE, PIPERAZINE AND N-METHYLPIPERAZINE
#4PHARMACEUTICAL COMPOSITION COMPRISING TIZOXANIDE AND PHARMACEUTICAL USE THEREOF
#5Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereof
#6Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereof
#7Tizoxanide phosphate and alkane sulfonate and pharmaceutical applications thereof
#8Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereof
#9Tizoxanide carbamate and pharmaceutical use thereof
#10NOVEL TARGETING AGENTS FOR DIAGNOSTIC AND THERAPEUTIC INDICATIONS
#11Broad spectrum benzothiophene-nitrothiazolide and other antimicrobials
#12Thiazole compounds, methods for preparation and use thereof
#13Glutamate receptor modulators and therapeutic agents
#14Heterocyclic CETP inhibitors
#15Bridged spiro [2.4] heptane derivatives as ALX receptor and/or FPRL2 agonists
#16Broad spectrum benzothiophene-nitrothiazolide and other antimicrobials
#17Amide thiazole derivative, preparation method and uses thereof
#18Chiral 2-(benzylsulfinyl)thiazole derivatives and 2-[(1H-pyrazol-4-ylmethyl)sulfinyl]thiazole derivatives, processes for their preparation and their use as herbicides and plant growth regulators
#19Heterocyclic CETP inhibitors
#20Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
#21Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
#22Glutamate receptor modulators and therapeutic agents
#23PREPARATION AND USE OF ARYL ALKYL ACID DERIVATIVES FOR THE TREATMENT OF OBESITY
#24Stilbene like compounds as novel HDAC inhibitors
#25FBPase inhibitors for diabetes
#26Heteroaromatic glucokinase activators
#27Heterocyclic CETP inhibitors
#28Hydroxysteroid dehydrogenase inhibitors
#29Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
#30New 2-substituted - 1,3-thiazole compounds
#31Heteroaromatic glucokinase activators
#322-substituted-1,3-thiazole compounds
#334-(4Methoxybenzyl)-nā²-(5-nitro1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3 (gsk3)